Literature DB >> 2028321

Vascular complications of lumbar decompression laminectomy and foraminotomy. A unique case and review of the literature.

D W Smith1, B D Lawrence.   

Abstract

The possibility of vascular injury should always be kept in mind during lumbar laminectomy. Patients with pre-existing vascular disease are predisposed to injury. Unexplained hypotension is highly suggestive of a vascular catastrophe and is an indication for more detailed examination, sometimes laparotomy. If the patient's clinical condition is stable, consider arteriography. The development of high-output cardiac failure in a patient who has recently undergone lumbar laminectomy is almost diagnostic of traumatic arteriovenous fistula. The best prognosis for recovery of acute vascular interruption occurs with immediate treatment within 24-48 hours. Continued awareness of the possible occurrence of these injuries and familiarity with their various manifestations will facilitate early diagnosis, prompt operative repair, and improved mortality.

Entities:  

Mesh:

Year:  1991        PMID: 2028321     DOI: 10.1097/00007632-199103000-00030

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  3 in total

Review 1.  Visceral, vascular, and wound complications following over 13,000 lateral interbody fusions: a survey study and literature review.

Authors:  Juan S Uribe; Armen R Deukmedjian
Journal:  Eur Spine J       Date:  2015-02-27       Impact factor: 3.134

2.  Novel posterior technique to temporize life-threatening hemorrhage after great vessel laceration during posterior osteotomy.

Authors:  Wayne K Cheng; Phillip A Ta; Ahmed M Abou-Zamzam; Yusuf T Akpolat; Phillip T Guillen
Journal:  Eur Spine J       Date:  2015-04-11       Impact factor: 3.134

3.  Vascular complications in lumbar disk surgery: report of four cases.

Authors:  D H Szolar; K W Preidler; H Steiner; T Riepl; G Flaschka; M Stiskal; S Moelleken; D Norman
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.